Peak flow in heart failure
ISRCTN | ISRCTN83265463 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN83265463 |
Secondary identifying numbers | N0159093858 |
- Submission date
- 12/09/2003
- Registration date
- 12/09/2003
- Last edited
- 05/12/2014
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr Philip Snashall
Scientific
Scientific
Professor of Medicine
North Tees & Hartlepool NHS Trust
North Tees General Hospital
Stockton-on-Tees
TS19 8PE
United Kingdom
Study information
Study design | Randomised double blind trial |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Hospital |
Study type | Treatment |
Scientific title | Peak flow in heart failure |
Study objectives | Does treatment with ipratropium bromide (Atrovent) improve peak flow and associated symptoms? |
Ethics approval(s) | Not provided at time of registration |
Health condition(s) or problem(s) studied | Cardiovascular: Heart failure |
Intervention | Ipratropium bromide vs standard practice |
Intervention type | Drug |
Pharmaceutical study type(s) | |
Phase | Not Applicable |
Drug / device / biological / vaccine name(s) | Ipratropium bromide |
Primary outcome measure | Improvement in peak flow rates and other symptoms. |
Secondary outcome measures | Not provided at time of registration |
Overall study start date | 01/02/2001 |
Completion date | 01/04/2004 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Not Specified |
Sex | Not Specified |
Target number of participants | Not provided at time of registration |
Key inclusion criteria | Patients with heart failure |
Key exclusion criteria | Not provided at time of registration |
Date of first enrolment | 01/02/2001 |
Date of final enrolment | 01/04/2004 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
North Tees & Hartlepool NHS Trust
Stockton-on-Tees
TS19 8PE
United Kingdom
TS19 8PE
United Kingdom
Sponsor information
Department of Health (UK)
Government
Government
Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom
Website | http://www.doh.gov.uk |
---|
Funders
Funder type
Hospital/treatment centre
North Tees and Hartlepool NHS Trust (UK)
No information available
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |